treatment low doses macrolides widely applied management patients chronic inflammatory diseases diffuse panbronchiolitis chronic bronchitis chronic lung damage newborns physiological mechanisms underlying action macrolides conditions unclear clarify pathological basis diseases aid design novel drugs treat chose investigate molecular targets macrolides experiments involved culture human small airway epithelial cells hsaec media containing macrolides erythromycin em clarithromycin cam macrolide josamycin jm lacks clinical effects analyzed gene expression profiles treated cells using cdna microarray consisting NUMBER genes identified genes expression significantly altered NUMBER days culture em seven altered cam time genes revealed similar behavior cells treated macrolides jm products genes candidates mediating ability macrolides suppress chronic inflammation copyright NUMBER academic press long term NUMBER membered long term NUMBER membered NUMBER membered anti inflammatory NUMBER membered NUMBER membered